For Malaria, We Just Can't Afford to Use Cheap Drugs

View on Financial Times website

Date

March 13, 2009

News Type

Media Highlight

Source

Financial Times

There are two ways to take anti-malarial drugs: the expensive way, which helps the world; and the cheap way, which helps only the patient. Most Africans cannot afford the expensive way and, as a result, the worlds most effective anti-malarial drug may lose its potency.

Related Content

Webinar — Oct 21, 2025

The US Nuclear Future: Learning from Recent Experience and Confronting Future Challenges

Join RFF for a two-part event discussing the challenges and opportunities of a potential nuclear renaissance in the United States.

Common Resources — Sep 25, 2025

Incentivizing Superhot Rock Geothermal Exploration

Superhot rock geothermal wells could help the United States meet rising electricity demand. However, a lack of geological information means that drilling these expensive wells is risky. Two types of programs could provide needed geological information.

Report — Sep 25, 2025

Corporate Due Diligence, Auto Industry, and Battery Supply Chains

This report suggests that the European Union's Corporate Sustainability Due Diligence Directive is a useful framework for harmonizing existing national-level regulations on the corporate due diligence of critical mineral supply chains.

Resources Radio — Sep 23, 2025

Airing New Concerns with US Carbon Capture Policies, with Sheila Olmstead

Sheila Olmstead discusses the complex nature of federal subsidies related to carbon capture and storage. These subsidies might reduce carbon emissions—but also can be expensive, discourage clean energy projects, and motivate more pollution.